NeuroBo Pharmaceuticals Confirms Marshall Woodworth As New CFO
Biotechnology company NeuroBo Pharmaceuticals, Inc. (NRBO) announced Monday the appointment of Marshall Woodworth as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective March 1, 2024, following his tenure as Acting Chief Financial Officer since October 27, 2023. Marshall brings in decades of experience as a CFO for a variety of pharmaceutical and...